We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Authors
Sanchorawala, Vaishali; Palladini, Giovanni; Minnema, Monique C.; Jaccard, Arnaud; Lee, Hans C.; Gibbs, Simon; Mollee, Peter; Venner, Christopher; Lu, Jin; Schönland, Stefan; Gatt, Moshe; Suzuki, Kenshi; Kim, Kihyun; Cibeira, María Teresa; Beksac, Meral; Libby, Edward; Valent, Jason; Hungria, Vania; Wong, Sandy W.; Rosenzweig, Michael
- Publication
American Journal of Hematology, 2022, Vol 97, Issue 6, p719
- ISSN
0361-8609
- Publication type
Article
- DOI
10.1002/ajh.26536